1.0Bioceltixhttps://nervous-vaughan.46-242-130-154.plesk.page/en/adminhttps://nervous-vaughan.46-242-130-154.plesk.page/en/author/bartoszcebrzyna/rich600338<blockquote class="wp-embedded-content" data-secret="U42onBiAE7"><a href="https://nervous-vaughan.46-242-130-154.plesk.page/en/biologics/">Biologics</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://nervous-vaughan.46-242-130-154.plesk.page/en/biologics/embed/#?secret=U42onBiAE7" width="600" height="338" title="“Biologics” — Bioceltix" data-secret="U42onBiAE7" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script> /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); //# sourceURL=https://nervous-vaughan.46-242-130-154.plesk.page/wp-includes/js/wp-embed.min.js </script> Biologics Pipeline Our top priority is to ensure patient safety and therapeutic efficacy in the development of veterinary mesenchymal stem cell (MSC) based biologics. Our current pipeline includes advanced development programs designed for canine and equine patients. Two of our products are intended for dogs — one addresses osteoarthritis (OA), while the other is designed […]